{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:55:36Z","timestamp":1788666936492,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ijcard.2015.03.324","type":"journal-article","created":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T13:49:30Z","timestamp":1427550570000},"page":"66-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Antiarrhythmic properties of ranolazine: A review of the current evidence"],"prefix":"10.1016","volume":"187","author":[{"given":"Tanush","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaval","family":"Kolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.03.324_bb0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000358871","article-title":"Use of ranolazine in patients with stable angina pectoris","volume":"128","author":"Khera","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2015.03.324_bb0010","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(08)61554-8","article-title":"Ranolazine for chronic stable angina","volume":"372","author":"Nash","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2015.03.324_bb0015","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/CIRCULATIONAHA.105.597500","article-title":"Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions","volume":"113","author":"Chaitman","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.324_bb0020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijcard.2013.08.131","article-title":"Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis","volume":"169","author":"Savarese","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0025","first-page":"376","article-title":"Ranolazine: drug overview and possible role in primary microvascular angina management","volume":"181C","author":"Cattaneo","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2004.03.066","article-title":"Treatment of refractory angina pectoris","volume":"101","author":"Gowda","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijcard.2012.07.001","article-title":"Angina pectoris in women: focus on microvascular disease","volume":"163","author":"Zuchi","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijcard.2007.10.042","article-title":"Metabolic agents in the management of diabetic coronary patients: a new era","volume":"127","author":"Marazzi","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/1074248412442000","article-title":"A focus on antiarrhythmic properties of ranolazine","volume":"17","author":"Vizzardi","year":"2012","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0050","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2174\/09298673113209990220","article-title":"Late sodium current inhibition: the most promising antiarrhythmic principle in the near future?","volume":"21","author":"Frommeyer","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijcard.2011.06.012","article-title":"Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits","volume":"155","author":"Camm","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0060","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/j.ijcard.2013.12.236","article-title":"Combination use of ranolazine with dofetilide for the maintenance of atrial fibrillation","volume":"172","author":"Shah","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijcard.2013.11.066","article-title":"Successful treatment of a patient with symptomatic long QT syndrome type 3 using ranolazine combined with a beta-blocker","volume":"171","author":"van den Berg","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0070","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties","volume":"110","author":"Antzelevitch","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.324_bb0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00005344-200408000-00008","article-title":"Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes","volume":"44","author":"Song","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2015.03.324_bb0080","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1111\/j.1540-8167.2006.00401.x","article-title":"Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current","volume":"17","author":"Undrovinas","year":"2006","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0085","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/CIRCULATIONAHA.107.704890","article-title":"Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine","volume":"116","author":"Burashnikov","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.324_bb0090","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.jacc.2009.12.055","article-title":"Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium","volume":"55","author":"Sossalla","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0095","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.hrthm.2011.03.045","article-title":"Electrophysiologic basis for the antiarrhythmic actions of ranolazine","volume":"8","author":"Antzelevitch","year":"2011","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0100","first-page":"H561","article-title":"Effect of tetrodotoxin on action potentials of the conducting system in the dog heart","volume":"236","author":"Coraboeuf","year":"1979","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10557-012-6421-1","article-title":"Role of late sodium channel current block in the management of atrial fibrillation","volume":"27","author":"Burashnikov","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2174\/187152508785909447","article-title":"Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart","volume":"6","author":"Undrovinas","year":"2008","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0115","doi-asserted-by":"crossref","first-page":"H689","DOI":"10.1152\/ajpheart.2001.281.2.H689","article-title":"Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle","volume":"281","author":"Zygmunt","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0120","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/01.RES.71.5.1231","article-title":"Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine","volume":"71","author":"Undrovinas","year":"1992","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0125","first-page":"H1034","article-title":"Palmitoyl carnitine modifies sodium currents and induces transient inward current in ventricular myocytes","volume":"266","author":"Wu","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yjmcc.2008.03.006","article-title":"Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts\u2014role of late sodium current and intracellular ion accumulation","volume":"45","author":"Sossalla","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1540-8167.2001.00218.x","article-title":"Alterations of sodium channel kinetics and gene expression in the postinfarction remodeled myocardium","volume":"12","author":"Huang","year":"2001","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejheart.2006.08.007","article-title":"Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability","volume":"9","author":"Maltsev","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0145","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1172\/JCI26620","article-title":"Ca2+\/calmodulin-dependent protein kinase II regulates cardiac Na+ channels","volume":"116","author":"Wagner","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/CIRCRESAHA.110.221911","article-title":"Reactive oxygen species-activated Ca\/calmodulin kinase IIdelta is required for late I(Na) augmentation leading to cellular Na and Ca overload","volume":"108","author":"Wagner","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0155","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/FJC.0b013e318168e711","article-title":"Ranolazine inhibits an oxidative stress-induced increase in myocyte sodium and calcium loading during simulated-demand ischemia","volume":"51","author":"Zhang","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0160","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCULATIONAHA.110.943431","article-title":"Differential cardiac remodeling in preload versus afterload","volume":"122","author":"Toischer","year":"2010","journal-title":"Circulation"},{"issue":"Pt 3","key":"10.1016\/j.ijcard.2015.03.324_bb0165","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1113\/jphysiol.1997.sp022048","article-title":"Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes","volume":"500","author":"Ward","year":"1997","journal-title":"J. Physiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0170","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1124\/jpet.106.101832","article-title":"Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction","volume":"318","author":"Song","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0175","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/01.RES.0000251305.25604.b0","article-title":"Altered Na+ channels promote pause-induced spontaneous diastolic activity in long QT syndrome type 3 myocytes","volume":"99","author":"Fredj","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0180","doi-asserted-by":"crossref","first-page":"H1606","DOI":"10.1152\/ajpheart.00242.2011","article-title":"Mechanisms of atrial-selective block of Na(+) channels by ranolazine: I. Experimental analysis of the use-dependent block","volume":"301","author":"Zygmunt","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0185","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pharmthera.2011.11.003","article-title":"Role of ranolazine in angina, heart failure, arrhythmias, and diabetes","volume":"133","author":"Sossalla","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0190","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2015.03.324_bb0200","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","article-title":"Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina)","volume":"61","author":"Kosiborod","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0205","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jacc.2006.10.067","article-title":"Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE)","volume":"49","author":"Koren","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0210","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0215","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jacc.2009.01.037","article-title":"Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 trial","volume":"53","author":"Wilson","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0220","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.hrthm.2008.03.018","article-title":"Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations","volume":"5","author":"Sicouri","year":"2008","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0225","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1540-8167.2009.01437.x","article-title":"Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart","volume":"20","author":"Kumar","year":"2009","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0230","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/FJC.0b013e3181d26416","article-title":"Intrapericardial ranolazine prolongs atrial refractory period and markedly reduces atrial fibrillation inducibility in the intact porcine heart","volume":"55","author":"Carvas","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0235","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jelectrocard.2009.07.007","article-title":"Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation","volume":"42","author":"Antzelevitch","year":"2009","journal-title":"J. Electrocardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0240","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/CIRCRESAHA.114.302362","article-title":"Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation","volume":"114","author":"Woods","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0245","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0250","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1016\/j.ijcard.2013.07.183","article-title":"Distinctive sodium and calcium regulation associated with sex differences in atrial electrophysiology of rabbits","volume":"168","author":"Tsai","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0255","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jacc.2010.08.600","article-title":"Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation","volume":"56","author":"Burashnikov","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0260","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCEP.109.886275","article-title":"Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria","volume":"3","author":"Sicouri","year":"2010","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0265","first-page":"175","article-title":"The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation","volume":"8","author":"Murdock","year":"2008","journal-title":"Indian Pacing Electrophysiol. J."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0270","first-page":"260","article-title":"The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience with implications for possible \u201cpill in the pocket\u201d approach to atrial fibrillation","volume":"9","author":"Murdock","year":"2009","journal-title":"Indian Pacing Electrophysiol. J."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0275","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.amjcard.2011.04.017","article-title":"Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting","volume":"108","author":"Miles","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0280","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2015.03.324_bb0285","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.107.724880","volume":"116","author":"Scirica","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2015.03.324_bb0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/europace\/euu217","article-title":"Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial","volume":"17","author":"Scirica","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2015.03.324_bb0310","doi-asserted-by":"crossref","first-page":"H2031","DOI":"10.1152\/ajpheart.01357.2007","article-title":"An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes","volume":"294","author":"Song","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0315","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12576-010-0092-0","article-title":"Late sodium current contributes to diastolic cell Ca2+ accumulation in chronic heart failure","volume":"60","author":"Undrovinas","year":"2010","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0320","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/jpet.109.156471","article-title":"Ranolazine antagonizes the effects of increased late sodium current on intracellular calcium cycling in rat isolated intact heart","volume":"331","author":"Wasserstrom","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0325","doi-asserted-by":"crossref","first-page":"H1048","DOI":"10.1152\/ajpheart.00467.2009","article-title":"Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart","volume":"297","author":"Wu","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0330","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.hrthm.2008.06.017","article-title":"Inhibition of the Na+\/Ca2+ exchanger suppresses torsades de pointes in an intact heart model of long QT syndrome-2 and long QT syndrome-3","volume":"5","author":"Milberg","year":"2008","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0335","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1124\/jpet.104.066100","article-title":"Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome","volume":"310","author":"Wu","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0340","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1124\/jpet.105.094862","article-title":"An increase in late sodium current potentiates the proarrhythmic activities of low-risk QT-prolonging drugs in female rabbit hearts","volume":"316","author":"Wu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0345","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jacc.2009.10.033","article-title":"Late Na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model","volume":"55","author":"Antoons","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2015.03.324_bb0350","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1177\/107424840400900106","article-title":"Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent","volume":"9","author":"Antzelevitch","year":"2004","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0355","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1540-8167.2008.01204.x","article-title":"Effect of ranolazine on ventricular vulnerability and defibrillation threshold in the intact porcine heart","volume":"19","author":"Kumar","year":"2008","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0360","doi-asserted-by":"crossref","first-page":"H1923","DOI":"10.1152\/ajpheart.00173.2009","article-title":"Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia\u2013reperfusion","volume":"297","author":"Dhalla","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0365","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1074248410386485","article-title":"First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia\/reperfusion model","volume":"16","author":"Kloner","year":"2011","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0370","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.hrthm.2010.11.029","article-title":"Antifibrillatory effect of ranolazine during severe coronary stenosis in the intact porcine model","volume":"8","author":"Nieminen","year":"2011","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0375","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jacc.2010.07.045","article-title":"Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine","volume":"57","author":"Morita","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0380","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cardfail.2012.10.017","article-title":"New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia","volume":"18","author":"Frommeyer","year":"2012","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0385","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.hrthm.2012.08.029","article-title":"Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits","volume":"9","author":"Frommeyer","year":"2012","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0390","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.108.137729","article-title":"Antitorsadogenic effects of ({+\/\u2212})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits","volume":"325","author":"Wang","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0395","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.hrthm.2008.09.008","article-title":"Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine","volume":"5","author":"Wu","year":"2008","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0400","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1476-5381.2010.01181.x","article-title":"Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade","volume":"164","author":"Jia","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0405","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1540-8167.2008.01246.x","article-title":"Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome","volume":"19","author":"Moss","year":"2008","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0410","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1540-8159.2011.03208.x","article-title":"Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks","volume":"34","author":"Bunch","year":"2011","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0415","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.110.937136","volume":"122","author":"Scirica","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.324_bb0425","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/eurjhf\/hfs163","article-title":"Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure","volume":"14","author":"Frommeyer","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2015.03.324_bb0430","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/europace\/eus399","article-title":"Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness","volume":"15","author":"Milberg","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2015.03.324_bb0435","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.hrthm.2012.09.015","article-title":"Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia","volume":"10","author":"Verrier","year":"2013","journal-title":"Heart Rhythm."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315005641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315005641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T10:35:51Z","timestamp":1566470151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315005641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":83,"alternative-id":["S0167527315005641"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.324","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiarrhythmic properties of ranolazine: A review of the current evidence","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}